Documentation scienceplus.abes.fr version Bêta

À propos de : Synthesis and Biological Evaluation of New Asymmetrical Bisintercalators as PotentialAntitumor Drugs        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Synthesis and Biological Evaluation of New Asymmetrical Bisintercalators as PotentialAntitumor Drugs
has manifestation of work
related by
Author
Abstract
  • The good results obtained in the past decade with various types of potential bisintercalating agents, e.g., LU79553, DMP 840, BisBFI, MCI3335, WMC-26, BisAC, BisPA, and the asymmetrical derivative WMC-79(Chart 1), prompted us to investigate a new series of asymmetrical bisintercalators, compounds 1a−t (Chart2), which can combine the potentiality of bisintercalation with a possible different mechanism of action dueto two diverse chromophores. The DNA-binding properties of these compounds have been examined usingfluorometric techniques: target compounds are excellent DNA ligands, with a clear preference for bindingto AT-rich duplexes. In vitro cytotoxicity of these derivatives toward human hormone-refractory prostateadenocarcinoma cell line (PC-3) is described. Apoptosis assays of four selected compounds are also reported.Very potent cytotoxic compounds, some of them capable of inducing early apoptosis, have been identified.
article type
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata